Advanced image guidance more precisely targets sarcomas, reduces long-term side effects
the ONA take:
Image-guided radiotherapy can effectively treat soft tissue sarcomas in the extremities, significantly reducing long-term side effects without effecting survival rates, according to RTOG 0630, a multi-year, multi-institution phase 2 clinical trial conducted by the Radiation Therapy Oncology Group (RTOG), now conducting research as NRG Oncology.
For this study, more than 100 patients with extremity-based soft tissue sarcomas (STS) received pretreatment radiation therapy that used advanced imaging technology to target a substantially smaller area than typically targeted in treating this type of cancer.
A series of daily presurgery images of the tumor were digitally integrated with previous scans to plan a custom-tailored radiation dose that minimized exposure to adjacent healthy tissue.
Assessments 2 years later showed that long-term side effects were 10.5%. Results from a previous study in which patients received radiation to a larger area showed long-term side effects of 37%.
“Although radiation oncology is a technologically intense discipline, wisdom in using these technologies is essential for optimal outcomes,” commented the lead author of the paper.
Image-guided radiotherapy can effectively treat soft tissue sarcomas in the extremities.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|